Correlation Between Visa and Purple Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Purple Biotech, you can compare the effects of market volatilities on Visa and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Purple Biotech.

Diversification Opportunities for Visa and Purple Biotech

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Visa and Purple is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Visa i.e., Visa and Purple Biotech go up and down completely randomly.

Pair Corralation between Visa and Purple Biotech

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.16 times more return on investment than Purple Biotech. However, Visa Class A is 6.19 times less risky than Purple Biotech. It trades about 0.37 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.03 per unit of risk. If you would invest  28,365  in Visa Class A on August 28, 2024 and sell it today you would earn a total of  2,954  from holding Visa Class A or generate 10.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Visa Class A  vs.  Purple Biotech

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Visa and Purple Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Purple Biotech

The main advantage of trading using opposite Visa and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.
The idea behind Visa Class A and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios